Skip to main content
. 2016 Jul 16;7(32):51934–51942. doi: 10.18632/oncotarget.10623

Figure 1. Inhibition of RPMI8266 and U266 human MM cell proliferation.

Figure 1

(A) Proliferation of RPMI8266 and U266 cells human MM cells was dose-dependently decreased by treatment with chloramphenicol for 48 h. IC50 values were 142.45 μg/ml and 315.22 μg/mL at 48 h with RPMI8266 and U266 cells, respectively. (B) The proliferation of human MM cell lines was decreased by chloramphenicol in a time-dependent manner (chloramphenicol: 100 μg/mL). (C) Proliferation of normal PBMCs was weakly decreased by chloramphenicol. Results are expressed as the mean ± SEM (error bars) for four separate experiments; *P < 0.05.